Introduction: Intra-amniotic inflammation is defined by elevated inflammatory biomarkers in the amniotic fluid (AF), either due to microbial invasion of the amniotic cavity (MIAC) or sterile inflammation. Amniocentesis being an invasive procedure, we wanted to investigate whether elevated matrix metalloproteinase-8 (MMP-8) or interleukin-6 (IL-6) concentrations could be detected from cervical fluid samples. Materials and Methods: This prospective study included 67 women with singleton nondiabetic pregnancies with or without preterm premature rupture of membranes (PPROM) between 22 +0 and 37 +0 weeks of gestation. Simultaneous AF and cervical samples were obtained. Results: In women without PPROM, cervical MMP-8 concentrations correlated with AF MMP-8 concentrations (r S = 0.466, p = 0.002), but cervical IL-6 did not correlate with AF IL-6 (r S = 0.277, p = 0.076). In PPROM cases no correlations were found. Women with MIAC had higher concentrations of AF MMP-8 and AF IL-6 compared to women without MIAC regardless of membrane status. However, only women without PPROM had higher concentrations of cervical MMP-8 in proven MIAC. Conclusion: In women without PPROM, cervical MMP-8 concentration reflects the magnitude of AF MMP-8, thus potentially guiding the selection of patients benefitting from amniocentesis.
Introduction
Matrix metalloproteinase-8 (MMP-8), a collagencleaving enzyme released by neutrophils, is a key component in the degradation of extracellular matrix in conditions such as periodontitis, cardiovascular disease, rheumatoid arthritis, and cancer [1] [2] [3] . Interleukin-6 (IL-6), a proinflammatory cytokine secreted by macrophages and
Materials and Methods
This prospective cohort study of 67 women with singleton pregnancies between 22 +0 and 37 +0 weeks of gestation undergoing amniocentesis was performed at the Department of Obstetrics and Gynecology, Helsinki University Hospital, Finland, from June 2013 to July 2017.
Ultrasound-guided transabdominal amniocentesis was performed by an experienced perinatologist in sterile conditions for suspected IAI (n = 55), assessment of fetal lung maturity (n = 8), trisomy-PCR or karyotype assessment (n = 3), or amnioreduction for polyhydramnios (n = 1). A cervical swab sample was obtained simultaneously by inserting a sterile swab into the cervical canal and rotating it for 15 s during speculum examination. The swabs were then each swirled in their respective extraction solution for 15 s.
Women with insulin-dependent diabetes mellitus, vaginal bleeding, or fetal chromosomal abnormality were excluded from the study. Women with and without preterm premature rupture of membranes (PPROM) were both included, but the results were assessed in separate subgroups. Gestational age was determined by the crown-rump length at the time of the first-trimester ultrasonography screening.
PPROM was diagnosed with a positive insulin-like growth factor binding protein test (ActimProm; Medix Biochemica, Espoo, Finland). Women with PPROM were managed following the current clinical guidelines, including routine administration of cefuroxime 1.5 × 3 g intravenously for 3 consecutive days and a single dose of azithromycin 1 g orally on admission. Women presenting with imminent labor before the 35th week of gestation received antenatal corticosteroids regardless of membrane status. The use of antenatal steroids, antibiotics, vaginal progesterone, and nonsteroidal anti-inflammatory drugs used by the women within 1 week prior to sampling is given in Table 1. IAI was suspected in the presence of contractions with at least one of the following criteria: uterine tenderness, fetal tachycardia, infectious cervical discharge, increased maternal plasma C-reactive protein > 10 mg/L, total blood white cell count > 20 × 10 9 /L, or visible sludge during transvaginal ultrasound examination. Decisions concerning the management of suspected IAI were left to the attending physician's discretion. The clinicians were blinded to the cervical and AF MMP-8 and IL-6 results.
MIAC was defined as a positive AF culture or bacterial 16S rDNA gene sequencing (AF-PCR). AF-PCR was performed for each sample, and in 50 (75%) cases an additional bacterial culture was available. For the bacterial AF-PCR a minimum of 500 µL of AF was subjected to ceramic bead-beating cell lysis (Precellys ® 24 tissue homogenizer; Bertin Technologies, France) followed by magnetic-bead-based DNA extraction method (NucliSENS kit with easyMAG automatic nucleic acid purification platform; bioMérieux, Marcy l'Étoile, France) as described by the manufacturer. The extracted DNA was amplified in duplicate by PCR using the following primers: 5′-TTG GAG AGT TTG ATC MTG GCT C-3′ (forward) and 5′-GTA TTA CCG CGG CTG CTG-3′ (reverse). DNA of lambda phage served as an inhibition control in the PCR reaction. A positive PCR product was verified by gel electrophoresis, 5 µL of the PCR product was sequenced in a core facility, and the obtained sequence was compared to the NCBI BLAST sequence database (www.ncbi.nlm.nih.gov/blast). Mixed sequences were analyzed by RipSeq mixed analysis tool (https://www.ripseq. com/) when appropriate.
The AF samples of 50 (75%) women were also cultured in both aerobic and anaerobic conditions, on chocolate blood agar in 5% CO 2 and on fastidious anaerobe agar at 35 ± 1 ° C with thioglycolate broth enrichment, enabling also the detection of common Candida species and Mycoplasma hominis, but not Ureaplasma species. The samples were cultured for 7 days and the results were inspected after days 1, 2, and 7.
Both AF and cervical sample solutions were frozen and stored at -20 ° C until analysis of MMP-8 and IL-6 concentrations. AF MMP-8 was quantified with a solid-phase immunoenzymometric assay (MMP-8 IEMA; Medix Biochemica, Espoo, Finland) in which microplate wells are coated with a monoclonal antibody against MMP-8 and the secondary antibody is conjugated to horseradish peroxidase, forming the enzyme conjugate used to detect the presence of human MMP-8. The analysis was performed according to the manufacturer's protocol and absorbance was measured at 414 nm with a microplate reader (Multiskan; Thermo Fisher Scientific, Vantaa, Finland). For IL-6 assessment, a commercial quantitative enzyme immunoassay kit (Quantikine ELI-SA, human IL-6; R&D Systems, Minneapolis, MN, USA) was used. Absorbance was measured at 450 nm with a microplate reader.
Statistical analyses were performed using IBM SPSS Statistics version 24 (Armonk, NY, USA). Categorical variables were compared by the χ 2 test or Fisher's exact test. Data with continuous variables not following a normal distribution were compared by the Mann-Whitney U test. Spearman's correlation was used to determine the relationship of two continuous variables. Biomarker concentrations were adjusted for gestational age at sample collection, time interval between PPROM and sampling, antenatal steroids, antibiotics, vaginal progesterone, and nonsteroidal anti-inflammatory drugs used within 1 week prior to sampling. A p value < 0.05 was considered significant.
Results
A total of 67 women with a mean gestational age of 28 +6 weeks (range 22
) at the time of sampling were enrolled. Of these women, 25 (37%) had PPROM prior to sampling, the median PPROM to sampling interval being 1.61 weeks (range 0-8.85 weeks) ( Table 1 ). There was no statistically significant difference between the mean gestational age at sampling in women with or without PPROM (28 +4 and 29 +0 weeks, respectively, p = 0.761). Women with proven MIAC had a significantly lower mean gestational age at sampling than women without MIAC (26 +6 and 29 +5 weeks, respectively, p = 0.008). Of the women who underwent amniocentesis due to suspected IAI (n = 55, 82%), 21 (31%) had MIAC. None of the 12 women undergoing amniocentesis for other reasons were diagnosed with MIAC ( Table 1) .
The median concentrations of AF MMP-8 and AF IL-6 were higher in women with PPROM than in women with intact membranes. However, after adjusting for gestational age at sampling, the differences were not significant. The median cervical MMP-8 and IL-6 concentrations did not differ between women with or without PPROM ( Table 2 ).
In the women without PPROM, cervical MMP-8 concentrations correlated with AF MMP-8 concentrations (r S = 0.466, p = 0.002), but cervical IL-6 did not correlate with AF IL-6 (r S = 0.277, p = 0.076) (Fig. 1) . In women with PPROM, no correlations between cervical and AF MMP-8 (r S = 0.319, p = 0.120) or cervical and AF IL-6 (r S = 0.346, p = 0.090) occurred (Fig. 2) .
In women without PPROM, the median concentrations of AF MMP-8, AF IL-6, and cervical MMP-8 were higher in cases with MIAC (n = 11) than in cases without MIAC (n = 31). After adjusting for gestational age at sampling, the differences were not significant. The median concentrations of cervical IL-6 did not differ between the subgroups with and without MIAC ( Table 3) .
In women with PPROM, the median concentrations of AF MMP-8 and AF IL-6 were higher among women with MIAC (n = 10) than in women without MIAC (n = 15). These differences were similarly not significant after adjusting for gestational age at sampling. Cervical MMP-8 and IL-6 concentrations did not differ between those with and without MIAC ( Table 3) . The microbial findings in AF samples are given in Table 4 .
Discussion
Our results demonstrated a correlation between the cervical and AF MMP-8 concentrations in women with intact membranes, but not in women with PPROM. No correlation between the concentrations of cervical and AF IL-6 was seen. Regardless of membrane status, women with MIAC had higher concentrations of AF MMP-8 and IL-6 compared to women without MIAC. In addition, the women without PPROM also had higher cervical concentrations of MMP-8 if they had MIAC compared to those not having MIAC, suggesting that cervical MMP-8 may have potential as a noninvasively obtainable biomarker for IAI, at least for women with intact membranes. There were no statistical differences between MIAC and non-MIAC women after adjusting for gestational age at sampling. However, this observation was expected, since the women with MIAC had significantly lower gestational age at sampling.
We acknowledge the major weakness of our study having a relatively small sample size. However, the clinical setting combined to the study's prospective nature and the simultaneous cervical and AF sampling offset this lack of power. To our best knowledge, this is the only study investigating the correlation between cervical and AF MMP-8, comparing the biomarker levels with and without PPROM and investigating cervical MMP-8 in MIAC patients. We are also aware of the possible confounding factors, such as administration of antenatal steroids and antibiotics during the study. Therefore, we adjusted the results for antenatal steroids, antibiotics, vaginal progesterone, and nonsteroidal anti-inflammatory drugs used within 1 week prior to sampling, but this did not change the results. Unfortunately, although AF-PCR was performed in all AF samples, bacterial cultures of 17 (25%) samples were lacking, which may have affected the detection of some microbial flora. However, it has been previously demonstrated that the number of bacterial species revealed by PCR is greater than that by cultures and includes as yet uncultivated taxa, and that the detection of MIAC by molecular methods has clinical significance Values are presented as median (range). AF, amniotic fluid; IL-6, interleukin-6; MIAC, microbial invasion of the amniotic cavity; MMP-8, matrix metalloproteinase-8; PPROM, preterm premature rupture of membranes. a Adjusted for gestational age at sampling. b Adjusted for gestational age, corticosteroid, antibiotics, vaginal progesterone, and nonsteroidal anti-inflammatory drug use within 1 week prior to sampling.
c Adjusted for time interval between PPROM and sampling.
DOI: 10.1159/000493207 [38] . We analyzed women with intact membranes and PPROM separately, since the clinical treatment and the origin of inflammation may differ between these groups [39] . We also studied both nulliparous and multiparous women, as parity-related variation in MMP-8 concentrations has previously been reported [11, 40] .
To the best of our knowledge, our current study is the first to address the correlation of cervical and AF MMP-8. We detected this correlation only in women without PPROM. Prior PPROM may have interfered with the detection of cervical MMP-8, or the negative result may be due to type II error caused by the small sample size. In addition, the mean PPROM to sampling interval was as long as 1.6 weeks, and the routine administration of antibiotics in PPROM might also have modified the intensity of the inflammatory response [41] . In order to consider the significance of the relatively long PPROM to sampling interval, we adjusted the results in women with PPROM for this potential confounder. However, the results did not change.
Holst et al. [42] found a weak correlation between cervical and AF IL-6 in women without PPROM, but this was not seen in our study. Musilova et al. [36] observed a strong correlation between vaginal and AF IL-6 concentrations in women with PPROM. However, their approach to sampling differed from ours (collection of AF from the vagina with a special syringe versus swab), which may explain some of the differences in the results.
Higher concentrations of AF MMP-8 were detected in women with PPROM than in women with intact membranes, as also reported by previous studies [7, 17] . However, this difference disappeared when we adjusted for gestational age at sampling, suggesting that gestational age and MIAC status are more important than membrane status. We found no difference in the cervical MMP-8 and IL-6 concentrations of women with or without PPROM.
We detected elevated concentrations of AF IL-6 in women with PPROM compared to women with intact membranes when MIAC status was not taken into consideration. This difference also disappeared when we ad- justed for gestational age. Lee et al. [43] separately assessed IAI and non-IAI cases, detecting no significant difference in the AF IL-6 concentrations between PPROM and non-PPROM in non-IAI cases. However, in women with IAI, the levels of AF IL-6 were decreased in PPROM cases. A similar trend was seen in our study, in which the women with MIAC and intact membranes also showed higher median concentrations of AF IL-6 than the women with MIAC and PPROM, although statistical difference was not reached (p = 0.387), perhaps due to the small sample size. Nevertheless, this may reflect a possible progression in the IAI sequence: the initial AF IL-6 peak followed by PPROM.
We observed that, regardless of membrane status, patients with MIAC had significantly higher concentrations of AF MMP-8 and IL-6 than those without MIAC, which is in line with previous IAI studies [19, 20, 22] . Moreover, cervical MMP-8 concentrations were higher in the subgroup of women without PPROM and with MIAC compared to women without PPROM and MIAC. Interestingly, this was not the case with cervical IL-6. On the contrary, a correlation of high cervical IL-6 and MIAC was previously observed both in women with and without PPROM [44, 45] . Holst et al. [42] investigated an array of different possible cervical biomarkers for MIAC in women without PPROM and found that cervical IL-6 was a good biomarker candidate. The difference in our results may be explained by the different detection methods, i.e., multiplex technology versus conventional ELISA.
Conclusion
Cervical MMP-8 and IL-6 concentrations do not reflect the exact intra-amniotic concentrations of these markers. Nevertheless, in women without PPROM, cervical MMP-8 concentration reflects the magnitude of AF MMP-8, thus potentially guiding the selection of patients benefitting from amniocentesis. Future studies with larger sample sizes are needed to define a clinically useful cutoff value for cervical MMP-8.
